These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33984155)

  • 21. Mal de Meleda.
    Urbina F; Cristóbal MC; Sandoval R
    Cutis; 1995 Oct; 56(4):235-8. PubMed ID: 8575224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutilating keratoderma.
    Schamroth JM
    Int J Dermatol; 1986 May; 25(4):249-51. PubMed ID: 2940194
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutilating palmoplantar keratoderma successfully treated with etretinate.
    Wereide K
    Acta Derm Venereol; 1984; 64(6):566-9. PubMed ID: 6084939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal de Meleda).
    Mozzillo N; Nunziata CA; Caracò C; Fazioli F; Botti G;
    J Surg Oncol; 2003 Dec; 84(4):229-33. PubMed ID: 14756434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel homozygous SLURP1 mutation in a Javanese family with Mal de Meleda.
    Radiono S; Pramono ZAD; Oh GGK; Surana U; Widiyani S; Danarti R
    Int J Dermatol; 2017 Nov; 56(11):1161-1168. PubMed ID: 29023701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mal de Meleda keratoderma with pseudoainhum.
    Bergman R; Bitterman-Deutsch O; Fartasch M; Gershoni-Baruch R; Friedman-Birnbaum R
    Br J Dermatol; 1993 Feb; 128(2):207-12. PubMed ID: 8457455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and genetic studies of 3 large, consanguineous, Algerian families with Mal de Meleda.
    Bouadjar B; Benmazouzia S; Prud'homme JF; Cure S; Fischer J
    Arch Dermatol; 2000 Oct; 136(10):1247-52. PubMed ID: 11030771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelanotic melanoma arising in an area of SLURP-1 mutated Mal de Meleda.
    Arousse A; Mokni S; H'mida Ben Brahim D; Bdioui A; Aounallah A; Gammoudi R; Saidi W; Boussofara L; Ghariani N; Denguezli M; Belajouza C; Nouira R
    Int J Dermatol; 2019 Aug; 58(8):966-968. PubMed ID: 30246339
    [No Abstract]   [Full Text] [Related]  

  • 29. Transgradient Variant of Mal De Meleda Presenting As Palmoplantar Keratoderma: A Case Report.
    Khan A; Singh A; Madke B; Gupta K; Sree Ramya T
    Cureus; 2024 May; 16(5):e60717. PubMed ID: 38903266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mal de Meleda with homozygous mutation p.G86R in SLURP-1.
    Jia WX; Zhang YY; Wu YD; Li WR; Cheng P; Bu WB; Li CR
    Int J Dermatol; 2020 Jun; 59(6):751-754. PubMed ID: 32048728
    [No Abstract]   [Full Text] [Related]  

  • 31. Report of a family with mal de Meleda in Taiwan: a clinical, histopathological and immunological study.
    Jee SH; Lee YY; Wu YC; Lü YC; Pan CC
    Dermatologica; 1985; 171(1):30-7. PubMed ID: 3161759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mal de Meleda with hyperpigmented spots.
    Baroni A; Piccolo V; Di Maio R; Romano F; Di Girolamo F; Satriano RA
    Eur J Dermatol; 2011; 21(3):459-60. PubMed ID: 21546336
    [No Abstract]   [Full Text] [Related]  

  • 33. Mal de Meleda: Diagnostic Work-up and Therapy with Low-dose Acitretin.
    Pospischil I; Enzelsberger K; Gross S; Hoetzenecker W; Fischer TW
    Acta Derm Venereol; 2022 Aug; 102():adv00758. PubMed ID: 35506361
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nail changes in Meleda disease].
    Salamon T
    Z Hautkr; 1982 Oct; 57(20):1496-504. PubMed ID: 6216676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal keratinization and cutaneous inflammation in Mal de Meleda.
    Kudo M; Ishiura N; Tamura-Nakano M; Shimizu T; Kamata M; Akasaka E; Nakano H; Okuma Y; Tada Y; Okochi H; Tamaki T
    J Dermatol; 2020 May; 47(5):554-558. PubMed ID: 32157724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of recurrent mutations in the ARS (component B) gene encoding SLURP-1 in two families with mal de Meleda.
    Ward KM; Yerebakan O; Yilmaz E; Celebi JT
    J Invest Dermatol; 2003 Jan; 120(1):96-8. PubMed ID: 12535203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudoainhum in Systemic Sclerosis.
    Silva M; Ribeiro R; Oliveira J
    J Rheumatol; 2016 Nov; 43(11):2076. PubMed ID: 27803345
    [No Abstract]   [Full Text] [Related]  

  • 38. Palmoplantar keratoderma--Mal de Meleda syndrome.
    Rajashekhar N; Moideen R
    Int J Dermatol; 1997 Nov; 36(11):854-6. PubMed ID: 9427080
    [No Abstract]   [Full Text] [Related]  

  • 39. Palmoplantar keratoderma of the Gamborg-Nielsen type is caused by mutations in the SLURP1 gene and represents a variant of Mal de Meleda.
    Zhao L; Vahlquist A; Virtanen M; Wennerstrand L; Lind LK; Lundström A; Hellström Pigg M
    Acta Derm Venereol; 2014 Nov; 94(6):707-10. PubMed ID: 24604124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in SLURP1 in patients with mal de Meleda from the Indian subcontinent.
    Nellen RG; Claessens T; Subramaniam R; Betkerur J; Prashanth A; Steijlen PM; van Geel M
    J Dermatol Sci; 2015 Oct; 80(1):76-8. PubMed ID: 26254200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.